BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 7897208)

  • 21. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
    Batten P; Yacoub MH; Rose ML
    Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of class II MHC molecules on human endothelial cells. Effects of IFN and dexamethasone.
    Manyak CL; Tse H; Fischer P; Coker L; Sigal NH; Koo GC
    J Immunol; 1988 Jun; 140(11):3817-21. PubMed ID: 2453556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB; Cestari S
    Cell Immunol; 1997 May; 178(1):79-90. PubMed ID: 9184701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells.
    Melrose J; Tsurushita N; Liu G; Berg EL
    J Immunol; 1998 Sep; 161(5):2457-64. PubMed ID: 9725244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
    Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
    Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines.
    Basta PV; Sherman PA; Ting JP
    J Immunol; 1987 Feb; 138(4):1275-80. PubMed ID: 3027177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-alpha, not CD154 (CD40L), plays a major role in SEB-dependent, CD4(+) T cell-induced endothelial cell activation in vitro.
    Baum D; Yaron R; Yellin MJ
    Cell Immunol; 1998 Nov; 190(1):12-22. PubMed ID: 9826442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein.
    Amaldi I; Reith W; Berte C; Mach B
    J Immunol; 1989 Feb; 142(3):999-1004. PubMed ID: 2492334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells.
    Lu Y; Ussery GD; Muncaster MM; Gallie BL; Blanck G
    Oncogene; 1994 Apr; 9(4):1015-9. PubMed ID: 8134104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo.
    Kara CJ; Glimcher LH
    J Immunol; 1993 Jun; 150(11):4934-42. PubMed ID: 8496595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of interferon-gamma-mediated immune functions by oligonucleotides. Suppression of human T cell proliferation by downregulation of IFN-gamma-induced ICAM-1 and Fc-receptor on accessory cells.
    Fedoseyeva EV; Li Y; Huey B; Tam S; Hunt CA; Benichou G; Garovoy MR
    Transplantation; 1994 Feb; 57(4):606-12. PubMed ID: 7906904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
    Guo TL; Mudzinski SP; Lawrence DA
    Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissection of the antigen presenting function of tissue cells induced to express HLA-DR by gamma interferon.
    Geppert TD; Lipsky PE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():59-62. PubMed ID: 3112378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class II expression on human heart microvascular endothelial cells: exquisite sensitivity to interferon-gamma and natural killer cells.
    McDouall RM; Batten P; McCormack A; Yacoub MH; Rose ML
    Transplantation; 1997 Oct; 64(8):1175-80. PubMed ID: 9355836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.
    Matikainen S; Paananen A; Miettinen M; Kurimoto M; Timonen T; Julkunen I; Sareneva T
    Eur J Immunol; 2001 Jul; 31(7):2236-45. PubMed ID: 11449378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.